Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Smoflipid vs Intralipid in neonates and infants requiring parenteral nutrition
NCT02579265Phase 3Terminated
- Sponsor
- Fresenius Kabi
- Start
- Dec 2015
- Primary completion
- Apr 2020
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 3 trial of SMOFlipid in Parenteral Nutrition Associated Liver Disease (PNALD), sponsored by Fresenius Kabi. Started Dec 2015; status: terminated.
02
Drugs
SMOFlipid
03
Conditions
Parenteral Nutrition Associated Liver Disease (PNALD)
Beyond the preview
Go deeper on NCT02579265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02579265.